Physician profile
Irving Zared Basanez
NPI 1740546894
$4,144.90
in general payments reported to CMS, 2019-2025
15 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $726 · 2020: $120 · 2021: $1,726 · 2022: $642 · 2023: $405 · 2024: $145 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.23 |
| Education | $151.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,711.11 | 2019-2022 | |
| Inspire Medical Systems, INC. | $1,349.48 | 2021-2025 | Inspire |
| Intersect Ent, INC. | $341.47 | 2019-2021 | |
| Cochlear Americas | $209.90 | 2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Regeneron Healthcare Solutions, INC. | $154.92 | 2023-2024 | Dupixent |
| Genzyme Corporation | $81.79 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $52.99 | 2023 | |
| Acclarent, INC | $49.99 | 2021-2023 | Acclarent Aera |
| Merck Sharp & Dohme LLC | $45.26 | 2023 | |
| Medtronic, INC. | $37.30 | 2024 | Nuvent |
| Tactile Systems Technology INC | $29.92 | 2019-2020 | |
| Glaxosmithkline, LLC. | $27.42 | 2024 | Nucala |
| Med-El Corporation | $21.77 | 2025 | Mi1250 Synchrony 2 Flexsoft |
| Ambu INC. | $16.46 | 2023 | |
| Coopersurgical, INC. | $15.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irving Basanez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.